485. Improved Outcome of COVID-19 in CAR T Cell Treated Patients; results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

BACKGROUND: COVID-19 has been associated with a very high mortality in patients having received CAR T cell treatment for hematological malignancies. The aim of this study was to investigate whether the outcome has improved over time. METHODS: This is a retrospective analysis of prospective data coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljungman, Per, Spanjaart, Anne M, Tridello, Gloria, Knelange, Nina, de la Camara, Rafael, Kersten, Marie Jose, Mielke, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678601/
http://dx.doi.org/10.1093/ofid/ofad500.555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678601/
http://dx.doi.org/10.1093/ofid/ofad500.555

Ejemplares similares